Autosomal dominant intellectual developmental disorder 39 is a rare genetic condition that affects learning, language, and development. Features often include mild to moderate intellectual disability and delays in speech and motor skills. Some people with Autosomal dominant intellectual developmental disorder 39 have behavioral differences or attention challenges, and not everyone will have the same experience. It is lifelong, usually recognized in early childhood, and survival is typically not affected. Support focuses on early intervention, speech and occupational therapy, educational supports, and regular follow-up with specialists.
Overview
Autosomal dominant intellectual developmental disorder 39Symptoms
Early signs of Autosomal dominant intellectual developmental disorder 39 include developmental delay, especially in speech and learning. Many have low muscle tone, coordination challenges, or autistic features; some develop seizures or feeding difficulties. Doctors may also note mild facial differences.
Outlook and prognosis
Most people with autosomal dominant intellectual developmental disorder 39 (ADDID 39) have lifelong learning and developmental differences, with abilities ranging from mild to more pronounced needs. Early therapies, educational supports, and care for associated medical issues can improve skills and independence. Many families see steady gains over time, though support needs often continue into adulthood.
Causes and risk factors
Autosomal dominant intellectual developmental disorder 39 results from a single gene change, inherited from an affected parent or arising new (de novo). Main risk is an affected parent; advanced paternal age increases de novo mutations; environment influences severity, not causation.
Genetic influences
Genetics play a central role in Autosomal dominant intellectual developmental disorder 39. A single altered gene copy typically causes the condition and can be inherited from an affected parent or arise as a new (de novo) change. Genetic testing confirms diagnosis and guides family planning.
Diagnosis
Doctors suspect Autosomal dominant intellectual developmental disorder 39 from developmental history, learning profile, and clinical features, sometimes with a family pattern. Genetic diagnosis of Autosomal dominant intellectual developmental disorder 39 is confirmed by testing, often a panel or exome.
Treatment and drugs
Treatment for Autosomal dominant intellectual developmental disorder 39 focuses on tailored supports that build skills and independence. Care often includes early developmental therapies, special education plans, behavioral strategies, and speech, physical, and occupational therapy. Genetic counseling and regular check-ins help adjust plans over time.
Symptoms
Autosomal dominant intellectual developmental disorder 39 affects development from infancy, especially speech, learning, and motor skills. Early features of Autosomal dominant intellectual developmental disorder 39 often include low muscle tone, delayed milestones like sitting or walking, and limited first words. Vision differences and feeding challenges in infancy can also show up. Features vary from person to person and can change over time.
Skills such as rolling, sitting, walking, and self-care tend to emerge later than expected. In Autosomal dominant intellectual developmental disorder 39, progress continues over time but often requires extra practice, therapy, and supports.
First words are often late and spoken language may stay limited. Many people understand more than they can say and use gestures, pictures, or speech devices to communicate. This pattern is common in Autosomal dominant intellectual developmental disorder 39.
Thinking and problem-solving often develop more slowly, and new skills may need extra repetition. Clinicians call this intellectual disability, which means lasting challenges with learning and daily living that benefit from tailored supports at school and home.
In medical terms, this is hypotonia; in everyday life, it shows up as a “floppy” feel in infancy, poor core strength, and getting tired with posture or chewing. It can affect sitting balance, handwriting, and endurance.
How people usually first notice Autosomal dominant intellectual developmental disorder 39?
Families often first notice signs of Autosomal dominant intellectual developmental disorder 39 in early childhood when developmental milestones—like first words, short phrases, or clear speech—arrive later than expected. Preschool or early school years may bring clearer clues: learning falls behind classmates, attention is short, and everyday problem-solving or social cues seem harder to pick up, prompting an evaluation. For many, these first signs of AUTSOMAL DOMINANT INTELLECTUAL DEVELOPMENTAL DISORDER 39 lead to developmental and genetic assessments that confirm the diagnosis and help guide supports.
Types of Autosomal dominant intellectual developmental disorder 39
Autosomal dominant intellectual developmental disorder 39 is a genetic condition with a few recognized clinical variants, which can differ in when challenges appear and how much support someone needs day to day. People may notice different sets of symptoms depending on their situation. Researchers describe these categories to better understand patterns of the condition. If you’re looking into types of Autosomal dominant intellectual developmental disorder 39, the variants below reflect consensus groupings seen in clinics and genetic reports.
Classic variant
Global learning differences start in early childhood and range from mild to moderate. Speech and language often develop more slowly, and everyday tasks may require extra teaching. Growth and physical health are usually typical.
With epilepsy
Core learning differences are present, and seizures occur in childhood or adolescence. Seizure control can vary, which sometimes affects attention and school performance. Many still reach personal milestones with tailored supports.
Behavioral-emotional prominent
Intellectual disability is accompanied by more noticeable anxiety, attention differences, or autistic features. Routines and social navigation may be harder, even when health is otherwise stable. School and home strategies focusing on behavior often help day-to-day function.
Mild cognitive form
Learning challenges are subtle and may be noticed later, such as during complex school tasks or job training. Daily independence is often high with targeted academic support. Not everyone will experience every type.
What genetics can tell you about symptoms
Changes in the MED13L gene can disrupt brain development, leading to developmental delay, speech problems, and intellectual disability, often with low muscle tone and feeding difficulties in infancy. Some people also have heart defects, distinctive facial features, and seizures linked to the same variant.
Causes and risk factors
The main cause is a new or inherited change in one gene that affects brain development. Some risks are written in our DNA, passed down through families. Known risk factors for Autosomal dominant intellectual developmental disorder 39 are having an affected parent and rare new gene changes at conception. If a parent has the gene change, each child has a 50% chance to inherit it, and many families have no history because the change happened for the first time. Lifestyle and environment do not cause the condition, but factors like older biological father age, pregnancy health, and early care can influence how symptoms present and daily function.
Environmental and biological risk factors
Autosomal dominant intellectual developmental disorder 39 begins before birth and typically results from a rare, one‑time change that happens as an egg or sperm forms or just after fertilization. Some risks are carried inside the body, others come from the world around us. While families often look for early symptoms of Autosomal dominant intellectual developmental disorder 39, the points below focus on biological and environmental factors that may slightly raise the chance of it occurring. Most pregnancies will not be affected, and even when these risks are present, the absolute chance generally remains low.
As sperm‑producing cells age, small copying errors become more likely when an embryo forms. This raises the chance of rare conditions present from birth, such as Autosomal dominant intellectual developmental disorder 39. Most children of older fathers are healthy.
Older eggs are more prone to errors when DNA is copied during early development. The effect for single‑gene conditions is modest compared with paternal age, but it can slightly increase the chance of Autosomal dominant intellectual developmental disorder 39. Most pregnancies at older maternal ages are unaffected.
High‑dose exposure before conception, such as cancer radiotherapy or significant occupational exposure, can damage sperm or eggs. This may slightly raise the chance of a new change that leads to conditions like this. Routine X‑rays and airport scanners use much lower doses and are not known to increase this risk.
Some chemotherapy medicines and radiation can temporarily harm the quality of sperm or eggs. This can raise the chance of new changes at conception. Care teams often recommend a waiting period before trying to conceive.
Genetic risk factors
Genetic changes in a single gene are the root cause, and one altered copy is enough to lead to this condition in a child or adult. Most families first learn about it when a new (de novo) variant appears in a child, though it can also be inherited. Risk is not destiny—it varies widely between individuals. Because early symptoms of Autosomal dominant intellectual developmental disorder 39 can be subtle, a mildly affected parent may not be diagnosed until a child is evaluated.
Single-gene change: A harmful change in one copy of a specific gene causes this condition. The change disrupts how the gene works and affects brain development. Different changes in the same gene can lead to a range of severity.
Autosomal dominant pattern: Only one altered copy is enough to cause features. Males and females are affected at similar rates. When inherited, the pattern can appear across generations.
De novo changes: In many families, the gene change arises for the first time in the child. Biological parents typically do not carry it in their blood. Recurrence risk after a true de novo event is usually low.
Recurrence risk: If a parent has the variant, each child has a 50% (1 in 2) chance of inheriting it. If testing shows a new change in the child, the chance for another affected child is small but not zero because of mosaicism. A genetic counselor can tailor numbers to your family.
Variable expressivity: Features and learning needs vary widely, even within one family. A mildly affected parent may be recognized only after a child is tested. This variability does not change transmission chances.
Parental mosaicism: A parent may carry the variant in only some body cells, which can blunt or hide features. Standard blood testing can miss low-level mosaicism. This can raise recurrence risk above the usual for de novo cases.
Germline mosaicism: Some parents have the variant only in egg or sperm cells. Blood tests can look normal even when this is present. This explains rare families with more than one affected child despite negative parental testing.
Copy-number changes: Small deletions or duplications that include the gene can cause the same condition. These structural changes are detected by chromosomal microarray or genome sequencing. Laboratories interpret them using standard clinical criteria.
Variant type effects: Changes that shorten the protein or disrupt key regions often have clearer effects than subtler letter changes. The exact spot of the change may influence which features are most prominent. Science continues to uncover how these elements interact.
Family history clues: A pattern of developmental delays or learning differences in close relatives can signal inherited disease. Because early symptoms of Autosomal dominant intellectual developmental disorder 39 can be subtle, family clues are sometimes overlooked. Sharing detailed family history can guide testing.
Lifestyle risk factors
Lifestyle does not cause Autosomal dominant intellectual developmental disorder 39, but daily habits can shape function, behavior, and long‑term health. Choosing supportive routines may ease learning, communication, and independence. Families often ask about how lifestyle affects Autosomal dominant intellectual developmental disorder 39; evidence and clinical experience show targeted habits can help. Below are practical elements often discussed as lifestyle risk factors for Autosomal dominant intellectual developmental disorder 39 in care planning.
Regular, individualized movement can improve motor coordination and stamina in ADID 39. It may also support attention and reduce restlessness, aiding participation in school and therapies.
Consistent bed and wake times can improve daytime focus, mood regulation, and learning. Good sleep may lower irritability and make therapies more effective.
Predictable schedules reduce anxiety and behavioral outbursts, improving participation in daily tasks. Visual supports and stepwise routines can speed skill acquisition.
Daily use of speech, sign, or AAC builds expressive and receptive language. Better communication often reduces frustration-driven behaviors and improves social participation.
Risk prevention
You can’t change the underlying genetics, but you can lower the chance of complications and support healthy development. Prevention is about lowering risk, not eliminating it completely. Recognizing early symptoms of Autosomal dominant intellectual developmental disorder 39 and acting quickly can help you get the right supports in place.
A genetics visit can explain inheritance and personal risks, including that an affected parent often has a 1-in-2 (50%) chance of passing it on. Counselors can also review testing options for you and family members.
If the family’s genetic change is known, options can include prenatal testing during pregnancy. Some may consider in‑vitro fertilization with preimplantation genetic testing to lower the chance of passing on the condition.
Ask for an early developmental evaluation and start speech, occupational, and physical therapy as soon as needs are identified. Starting supports early can improve communication, learning, and daily skills.
Schedule regular hearing and eye checks because sensory issues can worsen learning and behavior. Treating hearing or vision problems early reduces strain and supports therapy progress.
Transmission
Autosomal dominant intellectual developmental disorder 39 is not infectious—you can’t catch it from someone or pass it through everyday contact. It is inherited in an autosomal dominant way, meaning a single altered copy of the gene can cause the condition; if a parent has it, each child has a 50% (1 in 2) chance of inheriting it. In many cases, there’s no family history because the genetic change happens for the first time in the child (a new mutation). If you’re wondering how Autosomal dominant intellectual developmental disorder 39 is inherited in your family, a genetics professional can review testing results and discuss risks for future pregnancies.
When to test your genes
Consider genetic testing if you or a close relative have unexplained developmental delays, learning differences, or features a clinician suspects fit Autosomal dominant intellectual developmental disorder 39. Testing is also reasonable before pregnancy or if there’s a family history, to clarify risks and guide care. Talk with a genetic counselor to choose the right test and plan next steps.
Diagnosis
Everyday signs like delayed speech, learning differences, or trouble with problem-solving often prompt the first evaluation, sometimes in early childhood. In Autosomal dominant intellectual developmental disorder 39, doctors look for a pattern of developmental needs and health features and then use genetic tests to confirm the cause. Family history is often a key part of the diagnostic conversation. The goal is a clear answer so care, therapies, and school supports can be better tailored.
Providers review milestones like first words, walking, and social skills. This helps show the pattern and timing of concerns that may point toward Autosomal dominant intellectual developmental disorder 39.
Doctors look for recognizable features, growth patterns, and neurologic signs. These clinical features can raise suspicion and guide which genetic tests to order.
A three‑generation family tree looks for similar learning or developmental differences. This can reveal autosomal dominant patterns or suggest a new (de novo) change in Autosomal dominant intellectual developmental disorder 39.
A neurodevelopmental gene panel or exome/genome sequencing checks many genes at once. Finding a disease‑causing change confirms the genetic diagnosis of Autosomal dominant intellectual developmental disorder 39.
Stages of Autosomal dominant intellectual developmental disorder 39
Autosomal dominant intellectual developmental disorder 39 does not have defined progression stages. It’s a neurodevelopmental condition that shows up in early childhood and usually remains relatively stable over time, though learning and support needs can vary from person to person; families often first notice early symptoms of Autosomal dominant intellectual developmental disorder 39 like delayed speech or slower learning. Genetic testing may be offered to clarify certain risks. Diagnosis typically brings together your child’s developmental history, a physical and neurological exam, and learning or speech evaluations, and ongoing monitoring focuses on growth, behavior, communication, and education needs.
Outlook and prognosis
Looking at day-to-day life, many people with Autosomal dominant intellectual developmental disorder 39 (ADIDDI39) grow and learn over time, but at a different pace than peers. Early symptoms of ADIDDI39 can include delayed speech, learning challenges, and differences in attention or behavior; some also have low muscle tone or coordination issues. Everyone’s journey looks a little different. With therapies in place—speech, occupational, physical, and educational supports—many children make steady gains, and some adults live semi-independently with the right scaffolding.
This brings us to what doctors call the outlook, or prognosis. Most people with ADIDDI39 have a stable life expectancy, as the condition typically affects learning and development rather than vital organs. That said, coexisting issues—like seizures, sleep problems, or feeding difficulties in infancy—can influence health and require monitoring. Prognosis refers to how a condition tends to change or stabilize over time. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle. Early care can make a real difference, especially when therapy plans are updated as needs change from school years into adulthood.
Families often want to know how life will change as children become teens and adults. Over time, most people establish routines that work: structured school supports, social skills coaching, and, later, job training or supported employment. With ongoing care, many people maintain meaningful relationships and participate in community life. Talk with your doctor about what your personal outlook might look like, including which health checks to keep on the calendar and how to plan for education, independence, and support services. Genetic testing can sometimes provide more insight into prognosis, but not everyone with the same gene change will have the same outlook.
Long-term effects
Autosomal dominant intellectual developmental disorder 39 tends to have lifelong features that begin in childhood and continue into adulthood. Day to day, this often looks like ongoing learning differences, communication challenges, and varying levels of support in school, work, and daily life. Long-term effects vary widely, and strengths and challenges can look different from one person to the next. Most people do not experience steady worsening over time, but associated conditions like epilepsy, anxiety, or sleep issues can influence the long-term picture.
In Autosomal dominant intellectual developmental disorder 39, intellectual disability is typically mild to moderate and lifelong. Practical, hands-on skills often improve, while abstract reasoning stays harder.
Communication differences commonly persist into adulthood. Understanding language may be stronger than speaking, and expressive speech and articulation can remain challenging.
Fine and gross motor coordination often stay below average. Tasks like handwriting, buttons, or sports can remain effortful, though basic mobility is usually steady.
Ongoing features can include inattention, impulsivity, or autistic traits. Anxiety or mood difficulties may emerge or continue in adolescence and adulthood.
How is it to live with Autosomal dominant intellectual developmental disorder 39?
Living with autosomal dominant intellectual developmental disorder 39 often means learning and communication take extra time, and daily routines work best when they’re predictable and supported with visual cues or step-by-step guidance. Many find school and work settings more manageable with individualized education plans, speech and occupational therapy, and patience from teachers and employers. Families and caregivers may spend more time coordinating services and advocating in medical and educational systems, but they also often see strong progress with consistent supports and celebrate meaningful gains in independence. Friends, siblings, and partners can help by offering clear, calm communication, breaking tasks into smaller steps, and focusing on strengths, not just challenges.
Treatment and drugs
Treatment for Autosomal dominant intellectual developmental disorder 39 focuses on supports and therapies that build skills, ease day-to-day challenges, and address any associated medical or behavioral concerns. Supportive care can make a real difference in how you feel day to day. Care plans often include early intervention, speech and language therapy, occupational and physical therapy, educational supports, and behavioral strategies; doctors may also treat coexisting issues such as ADHD, anxiety, sleep problems, or seizures with standard medicines when needed. Regular check-ins help adjust goals as a child grows or as an adult’s needs change, and genetic counseling can guide families on testing, services, and future planning. Ask your doctor about the best starting point for you.
Non-drug treatment
People living with Autosomal dominant intellectual developmental disorder 39 often benefit from practical, day‑to‑day supports that build skills for communication, learning, and independence. Alongside medicines, non-drug therapies can strengthen core abilities and reduce frustration at home and school. Early intervention for Autosomal dominant intellectual developmental disorder 39 can help lay strong foundations during the most flexible years of development. Plans work best when they are tailored to each child’s strengths, challenges, and family routines.
Coordinated services in infancy and preschool can boost language, movement, and self-care skills. Starting early may improve school readiness and reduce later support needs.
Sessions target speech sounds, understanding, and social communication. Therapy can address limited words, apraxia-like speech challenges, or swallowing concerns if present.
Activities build fine-motor skills, hand strength, and everyday tasks like dressing or using utensils. Therapists also work on sensory processing to improve focus and comfort.
Exercises and play-based movement improve balance, coordination, and core strength. This can help with walking, stairs, and endurance for school and play.
Your genes may have an impact on how drugs work for you
Medicines for autosomal dominant intellectual developmental disorder 39 can work differently based on a person’s genes, which affect how drugs are absorbed, broken down, and reach the brain. Pharmacogenetic testing may guide dosing or drug choice, helping balance benefits and side effects.
Pharmacological treatments
There’s no single medication that treats Autosomal dominant intellectual developmental disorder 39 itself, so care focuses on easing specific symptoms that affect day-to-day life at home and school. Drugs that target symptoms directly are called symptomatic treatments. Plans are individualized and may change as needs evolve over time. Safety and benefits are reviewed regularly with a pediatrician, neurologist, or psychiatrist familiar with developmental conditions.
Methylphenidate or mixed amphetamine salts can improve focus and reduce hyperactivity. Non-stimulants like guanfacine, clonidine, or atomoxetine are options if stimulants aren’t well tolerated. Dosing may be increased or lowered gradually to balance benefits and side effects.
Levetiracetam, valproate, or lamotrigine are commonly used if seizures occur. The choice depends on seizure type, side-effect profile, and other medicines.
Risperidone or aripiprazole can reduce severe irritability, aggression, or self-injury that disrupts learning and care. Doctors monitor weight, lipids, and movement-related side effects during treatment.
SSRIs such as fluoxetine or sertraline may ease anxiety, repetitive worries, or low mood. Start low and increase slowly while watching for behavior activation or sleep changes.
Genetic influences
Genetics play a central role in Autosomal dominant intellectual developmental disorder 39. It follows an autosomal dominant pattern, meaning one altered copy of a gene is enough to cause the condition. A change in a gene (mutation or variant) can sometimes affect health, and in this condition it interferes with brain development and learning. Many people with Autosomal dominant intellectual developmental disorder 39 are the first in their family to be diagnosed because the change often arises for the first time (a de novo change). When a parent is living with the condition, each pregnancy carries a 50% chance of passing on the same gene change. Features can vary widely, even within one family, so the early symptoms of Autosomal dominant intellectual developmental disorder 39 may range from mild learning and speech delays to more noticeable developmental challenges. Most unaffected parents have a low chance of having another child with the condition, but a rare situation called mosaicism—when the change is present only in some egg or sperm cells—can slightly raise that risk. Genetic testing and counseling can confirm the cause and help families understand recurrence risks.
Is Autosomal dominant intellectual developmental disorder 39 genetic?
Genetics play a central role in Autosomal dominant intellectual developmental disorder 39. A single altered gene copy typically causes the condition and can be inherited from an affected parent or arise as a new (de novo) change. Genetic testing confirms diagnosis and guides family planning.
Pharmacogenetics—how genetics influence drug effects
For many living with Autosomal dominant intellectual developmental disorder 39, medicines are used to manage features like seizures, attention or behavior challenges, sleep difficulties, or anxiety, rather than to change the underlying gene change itself. Your genes can also influence how your body handles these medicines—some people break drugs down quickly, others more slowly—which can affect which drug works best, what dose is needed, and the chance of side effects. Alongside medical history and current medicines, genetic testing may help guide safer dosing or drug choice for some of these treatments. For example, common differences in liver enzyme genes can affect response to many antidepressants, attention medicines, and antiseizure drugs, and certain immune gene types are linked to rare but serious skin reactions with specific seizure medicines, particularly in people with East or Southeast Asian ancestry. These results don’t replace clinical judgment; they add one more piece of information, and your care team will still tailor treatment based on age, weight, other medicines, and kidney or liver health. Your care team can also advise whether pharmacogenetic testing could help fine‑tune medication choices in Autosomal dominant intellectual developmental disorder 39 when benefits are limited or side effects occur.
Interactions with other conditions
Day-to-day, coexisting conditions like ADHD, autism traits, anxiety, sleep problems, or epilepsy can shape how Autosomal dominant intellectual developmental disorder 39 affects learning, behavior, and independence. Doctors call it a “comorbidity” when two conditions occur together. When seizures are part of the picture, fevers, missed doses, or sleep loss can trigger episodes and temporarily worsen attention, behavior, or learning. Gut issues such as constipation or reflux, hearing or vision differences, and motor coordination challenges may also interact with communication and schooling needs in people with Autosomal dominant intellectual developmental disorder 39. Certain medicines for one issue—such as stimulants for ADHD, anti-seizure drugs, or sleep aids—can affect appetite, mood, and alertness, so teams often adjust doses to balance benefits and side effects. If you’re tracking early symptoms of Autosomal dominant intellectual developmental disorder 39 alongside other diagnoses, keeping notes on sleep, behavior, and seizure patterns can help your clinicians tailor care.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Families and communities once noticed patterns of delayed learning and similar facial features passing through several generations, long before there was a name for what we now call autosomal dominant intellectual developmental disorder 39. A grandmother might recall a relative who needed extra time in school, and later notice a child and then a grandchild with the same mix of strengths and challenges. Doctors initially recorded these family stories in brief case notes, focusing on everyday function more than genes, because the genetic tools simply didn’t exist.
First described in the medical literature as a cluster of developmental delays with subtle physical traits, it was grouped with other nonspecific intellectual disabilities. Over time, descriptions became more detailed as clinicians compared notes from different families and countries. Some early reports used umbrella terms that we no longer use today, reflecting the limits of the era’s knowledge. Not every early description was complete, yet together they built the foundation of today’s knowledge.
In recent decades, awareness has grown as genetic testing became part of routine evaluation for developmental concerns. Researchers began linking consistent clinical patterns to specific single-gene changes that follow an autosomal dominant pattern—meaning one altered copy of the gene can be enough to cause the condition. This shift moved the conversation from “what we see” to “why it happens,” letting clinicians connect scattered case reports into a single condition: autosomal dominant intellectual developmental disorder 39.
From early theories to modern research, the story of autosomal dominant intellectual developmental disorder 39 shows how naming a condition can improve care. As more families received a precise diagnosis, registries formed, natural history studies launched, and guidance for supportive therapies became clearer. Historical differences highlight why some people were once told their presentation was “non-syndromic” or “undifferentiated,” labels that changed once a molecular cause was identified.
Today, the history continues to evolve. Advances in genetics allow confirmation through DNA testing, and growing international collaboration helps define the full range of features, from early symptoms of developmental delay in infancy to learning and behavioral profiles in school-age years and adulthood. Knowing the condition’s history helps explain why older relatives may have had a different label—or no label at all—while younger generations can receive answers earlier and access tailored supports.